Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
SUPREP is an oral bowel preparation solution containing sodium sulfate, potassium sulfate, and magnesium sulfate used to cleanse the colon prior to colonoscopy or other GI procedures. It works as an osmotic laxative, drawing fluid into the bowel to produce evacuation. The solution-based formulation offers an alternative to powder or capsule-based prep agents.
Product faces significant competitive pressure (score: 30/100) with LOE approaching in August 2027, signaling a contracting team focused on retention and cost management.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on SUPREP offers exposure to GI procedure prep market dynamics and managed care negotiation in a pre-LOE environment where strategic pricing and retention become critical. Career growth is constrained by the product's mature status and approaching generic competition, making this role better suited for individuals seeking stability in commercial operations or those interested in defensive launch strategies.
Worked on SUPREP BOWEL PREP KIT at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo